Last reviewed · How we verify

NCT04961021

Management of Consecutive Exotropia

Completed NA Last updated 26 January 2022
What this trial tests

NA trial testing Strabismus surgery in Strabismus in 20 participants. Completed in 31 December 2021.

Timeline
3 August 2020
Primary endpoint
30 October 2021
31 December 2021

Quick facts

Lead sponsorMinia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment20
Start date3 August 2020
Primary completion30 October 2021
Estimated completion31 December 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

8 and older, any sex, with Strabismus or Concomitant Squint. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with consecutive exotropia will be managed by medial rectus muscle advancement +/- resection or medial rectus muscle advancement +/- lateral rectus recession

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Strabismus surgery

Trials testing the same drug.

Other recruiting trials for Strabismus

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04961021.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing